Supraclavicular Brachial Plexus Block as Opioid Sparing Technique in Pediatrics Undergoing Arteriovenous Fistula Creation
- Conditions
- Supraclavicular Brachial Plexus BlockOpioid SparingPediatricArteriovenous Fistula
- Registration Number
- NCT07012616
- Lead Sponsor
- Tanta University
- Brief Summary
This study aims to evaluate the efficacy of supraclavicular brachial plexus block as an opioid-sparing technique in pediatric patients undergoing arteriovenous fistula creation.
- Detailed Description
The global incidence of end-stage renal failure (ESRF) is increasing. The preferred procedure for patients with ESRF undergoing maintenance Haemodialysis (HD) is the placement of an arteriovenous fistula (AVF).
In patients with ESRF, brachial plexus block (BPB) is frequently employed to administer anesthesia for the establishment or modification of AVF. This technique offers pain relief, sympathetic blockade, ideal surgical conditions, and a sufficient duration of postoperative block, preventing arterial spasms and graft thrombosis
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 50
- Age from 6 to 18 years.
- Both sexes.
- American Society of Anesthesiology (ASA) physical status I- III.
- Undergoing arteriovenous fistula creation under general anesthesia.
- Allergy to local anesthetics.
- Infection at the site of block.
- Local infection.
- Coagulation disorder.
- Previously failed or revision of blocked arteriovenous fistula.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Intraoperative fentanyl consumption Intraoperatively
- Secondary Outcome Measures
Name Time Method Total opioid consumption 24 hours postoperatively Rescue analgesia of 0.5 µg/kg fentanyl will be given if the Wong-Baker score is 4 more.
Time to the 1st rescue analgesia 24 hours postoperatively Time to the first request for the rescue analgesia (time from end of surgery to the first dose of fentanyl administrated) will be assessed.
Degree of pain 24 hours postoperatively Degree of pain will be assessed using Wong-Baker score (0 to 10), 0= no hurt and 10= hurts worst. Wong-Baker score will be assessed at post-anesthesia care unit (PACU), 4, 6, 8, 12, 18 and 24 h postoperatively.
Patient satisfaction 24 hours postoperatively Degree of patient satisfaction will be assessed on a 5-point Likert scale patient satisfaction (1, extremely dissatisfied; 2, unsatisfied; 3, neutral; 4, satisfied; 5, extremely satisfied).
Incidence of adverse events 24 hours postoperatively Incidence of adverse events such as local anesthetic systemic toxicity (LAST), bradycardia, hypotension, PONV, respiratory depression, or any other complication will be recorded.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Tanta University
🇪🇬Tanta, El-Gharbia, Egypt
Tanta University🇪🇬Tanta, El-Gharbia, EgyptMohammed S Elsharkawy, MDContact00201148207870mselsharkawy@med.tanta.edu.egSaad A Moharam, MDPrincipal InvestigatorSara M Elghoul, MDPrincipal Investigator